Page last updated: 2024-08-22

nootkatone and Carcinoma, Non-Small Cell Lung

nootkatone has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SK; Hung, LVM; Moon, JY; Ryu, JY1

Other Studies

1 other study(ies) available for nootkatone and Carcinoma, Non-Small Cell Lung

ArticleYear
Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2019, Volume: 63

    Topics: A549 Cells; AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Proliferation; Citrus paradisi; Doxorubicin; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Metformin; Mice, Inbred BALB C; Mice, Nude; Polycyclic Sesquiterpenes; Proto-Oncogene Proteins p21(ras); Xenograft Model Antitumor Assays

2019